SG Americas Securities LLC Has $7 Million Stake in Revvity Inc. $RVTY

SG Americas Securities LLC trimmed its position in shares of Revvity Inc. (NYSE:RVTY) by 35.2% during the first quarter, HoldingsChannel reports. The institutional investor owned 79,874 shares of the company’s stock after selling 43,299 shares during the period. SG Americas Securities LLC’s holdings in Revvity were worth $6,998,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in RVTY. Vaughan Nelson Investment Management L.P. bought a new stake in shares of Revvity during the 1st quarter worth approximately $40,411,000. Corient Private Wealth LLC increased its stake in Revvity by 985.0% in the fourth quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock valued at $12,245,000 after acquiring an additional 114,903 shares during the last quarter. SHP Wealth Management acquired a new position in Revvity during the fourth quarter valued at approximately $100,000. Pacer Advisors Inc. raised its position in Revvity by 4.7% during the fourth quarter. Pacer Advisors Inc. now owns 11,152 shares of the company’s stock valued at $1,079,000 after purchasing an additional 504 shares in the last quarter. Finally, Virtu Financial LLC bought a new stake in Revvity during the fourth quarter worth $384,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on RVTY shares. Sanford C. Bernstein started coverage on Revvity in a research note on Friday. They issued a “market perform” rating and a $115.00 price target on the stock. Weiss Ratings upgraded Revvity from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Barclays lifted their target price on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Finally, Robert W. Baird set a $117.00 target price on Revvity in a research note on Wednesday, May 6th. Four equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $108.33.

Revvity Stock Down 0.0%

Shares of RVTY opened at $112.98 on Monday. The stock’s 50-day moving average price is $97.46 and its two-hundred day moving average price is $97.74. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $118.30. The company has a market capitalization of $12.60 billion, a PE ratio of 54.06, a PEG ratio of 2.47 and a beta of 1.11. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.04. The company had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, analysts anticipate that Revvity Inc. will post 5.25 EPS for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.